Sofinnova Investments

Sofinnova is a life-science-focused investment firm that deploys human and financial capital to advance therapeutic drug development. The firm reports approximately $3.3B in assets under management and invests in both private and public equity, with geographic focus across the U.S. and Europe. Sofinnova targets late preclinical and clinical-stage therapeutic companies and provides company-building support, regulatory and drug-development guidance, and board-level collaboration to advance programs toward IPO and commercialization.